| |
 |
|
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
194 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1,794 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1,046 |
| 424/277.1 |
Cancer cell or component thereof |
385 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
209 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
203 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
134 |
| 424/193.1 |
Conjugate or complex |
846 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
96 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
970 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
468 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
250 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
245 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
585 |
| 424/204.1 |
Virus or component thereof |
999 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7084249 |
Tumor associated antigen peptides and use of same as anti-tumor vaccines |
Aug. 1, 2006 |
| 7081244 |
Neisserial vaccine compositions and methods |
Jul. 25, 2006 |
| 7078036 |
Modulation of cholesteryl ester transfer protein (CETP) activity |
Jul. 18, 2006 |
| 7078042 |
Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
Jul. 18, 2006 |
| 7074402 |
Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein C (APC) |
Jul. 11, 2006 |
| 7074407 |
Method for increasing HDL cholesterol level |
Jul. 11, 2006 |
| 7074410 |
Modified HCV peptide vaccines |
Jul. 11, 2006 |
| 7074416 |
Antigen of hybrid M protein and carrier for group A streptococcal vaccine |
Jul. 11, 2006 |
| 7074580 |
Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
Jul. 11, 2006 |
| 7074900 |
Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin |
Jul. 11, 2006 |
| 7070774 |
Antibodies that bind testis-specific insulin homolog polypeptides |
Jul. 4, 2006 |
| 7070779 |
POLYPEPTIDES CONTAINING POLYMORPHISMS OF THE REPEATED REGIONS OF PERTACTIN IN BORDETELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS, AND BORDETELLA BRONCHISEPTICA, THEIR USE IN DIAGNOSTICS, AND IN IM |
Jul. 4, 2006 |
| 7070780 |
Treatment of demyelinating autoimmune disease with ordered peptides |
Jul. 4, 2006 |
| 7070781 |
Nontoxic mucosal adjuvant |
Jul. 4, 2006 |
| 7070790 |
Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vac |
Jul. 4, 2006 |
| 7070791 |
Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunoassay |
Jul. 4, 2006 |
| 7071296 |
Plasmodium falciparum antigens inducing protective antibodies |
Jul. 4, 2006 |
| 7071303 |
Androgen regulated prostate specific nucleic acids |
Jul. 4, 2006 |
| 7071322 |
HIV envelope polynucleotides and immunogenic composition |
Jul. 4, 2006 |
| 7067119 |
Compounds and compositions for delivering active agents |
Jun. 27, 2006 |
| 7067135 |
Methods and compositions for the treatment and prevention of Staphylococcus aureus infections |
Jun. 27, 2006 |
| 7067138 |
Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
Jun. 27, 2006 |
| 7063841 |
Mammalian cell surface antigens; related reagents |
Jun. 20, 2006 |
| 7063846 |
Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis |
Jun. 20, 2006 |
| 7063847 |
Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
Jun. 20, 2006 |
| 7063848 |
Lipoglycan compositions and methods of treating parasitic infections |
Jun. 20, 2006 |
| 7063850 |
Protective antigen of group A Streptococci |
Jun. 20, 2006 |
| 7063854 |
Composition and methods for WTI specific immunotherapy |
Jun. 20, 2006 |
| 7064185 |
Antibody for human Cyr61 |
Jun. 20, 2006 |
| 7060274 |
Receptor specific transepithelial transport of therapeutics |
Jun. 13, 2006 |
| 7060276 |
Plasmodium falciparum AMA-1 protein and uses thereof |
Jun. 13, 2006 |
| 7060277 |
Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins |
Jun. 13, 2006 |
| 7060278 |
Bv8 nucleic acids and polypeptides with mitogenic activity |
Jun. 13, 2006 |
| 7060281 |
Groups of barrelia burgdorferi and borrelia afzelii that cause lyme disease in humans |
Jun. 13, 2006 |
| 7060789 |
Ricin-like toxins for treatment of cancer |
Jun. 13, 2006 |
| 7060800 |
Antibodies binding the TNF related protein, TNF-X |
Jun. 13, 2006 |
| 7060868 |
Autoimmune disease model animal |
Jun. 13, 2006 |
| 7056492 |
Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle |
Jun. 6, 2006 |
| 7056509 |
Antibody methods for selectively inhibiting VEGF |
Jun. 6, 2006 |
| 7056510 |
Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines |
Jun. 6, 2006 |
| 7056511 |
Inhibition of protein binding to mast cells |
Jun. 6, 2006 |
| 7056512 |
Method for down-regulating GDF-8 activity |
Jun. 6, 2006 |
| 7056517 |
Glucosyltransferase immunogens |
Jun. 6, 2006 |
| 7056689 |
Methods of treating and detecting cancer using viruses |
Jun. 6, 2006 |
| 7056697 |
FabK variant |
Jun. 6, 2006 |
| 7056901 |
Microgel particles for the delivery of bioactive materials |
Jun. 6, 2006 |
| 7052696 |
Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins |
May. 30, 2006 |
| 7052697 |
Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses |
May. 30, 2006 |
| 7052860 |
Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
May. 30, 2006 |
| 7053041 |
Methods and compositions useful for inhibition of .alpha..sub.v.beta..sub.5mediated angiogenesis |
May. 30, 2006 |
|
|
|
